title: Indolamine 2,3-dioxygenase regulation and neuropsychiatric symptoms.
authors.affiliation: Research & Development Service, Portland VA Medical Center, 3710 SW U.S. Veterans Hospital Road, Portland, OR 97239, USA; Department of Psychiatry, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239-3098, USA. Electronic address: jennifer.loftis2@va.gov.
authors.forename: Jennifer M
authors.initials: JM
authors.lastname: Loftis
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects*; D001007:Anxiety / Q000139:chemically induced*; D003863:Depression / Q000139:chemically induced*; D005221:Fatigue / Q000139:chemically induced*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D054643:INDEL Mutation; D016898:Interferon-alpha / Q000009:adverse effects*; D015850:Interleukin-6 / Q000235:genetics*; D017354:Point Mutation; D011092:Polyethylene Glycols / Q000009:adverse effects*; D011994:Recombinant Proteins / Q000009:adverse effects; D012701:Serotonin / Q000502:physiology*; D050486:Serotonin Plasma Membrane Transport Proteins / Q000235:genetics*
chemical_list: D000998:Antiviral Agents; C508600:IL6 protein, human; D016898:Interferon-alpha; D015850:Interleukin-6; D011994:Recombinant Proteins; C493230:SLC6A4 protein, human; D050486:Serotonin Plasma Membrane Transport Proteins; D012701:Serotonin; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a
keywords: Anxiety; Cytokine; Depression; Inflammation; Tryptophan